Loading…
Insulet Corporation is projected to rise to $188.47 by 2027, a +14% move from its current price of $165.68. PODD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $162.38 | $165.72 | $169.13 | +0.03% |
| Aug 2 | $161.06 | $165.77 | $170.61 | +0.05% |
| Aug 3 | $160.07 | $165.81 | $171.77 | +0.08% |
| Aug 4 | $159.24 | $165.86 | $172.75 | +0.11% |
| Aug 5 | $158.52 | $165.90 | $173.63 | +0.13% |
| Aug 6 | $157.87 | $165.95 | $174.43 | +0.16% |
| Aug 7 | $157.29 | $165.99 | $175.18 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $157.29 | $165.99 | $175.18 | +0.19% |
| Week 2 | $154.11 | $166.30 | $179.47 | +0.38% |
| Week 3 | $151.77 | $166.62 | $182.91 | +0.57% |
| Week 4 | $149.88 | $166.93 | $185.92 | +0.75% |
| Week 5 | $148.26 | $167.24 | $188.65 | +0.94% |
| Week 6 | $146.85 | $167.56 | $191.19 | +1.13% |
| Week 7 | $145.57 | $167.87 | $193.59 | +1.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
PODD is the Insulet Corporation stock trading in Healthcare. It currently fetches a price of $159.79 per share, with a market cap of $11.07B and a market rank of 880. The stock sits in the Healthcare category.
A major floor 23.5% below — a decisive break under it would weaken the trend.
The nearest floor, 16.1% below — buyers have tended to step in here.
Price is pressing into resistance (3.0% away) — a breakout level to watch.
A major ceiling 37.1% above — clearing it would confirm fresh momentum.
Key PODD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PODD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $166.41 | Sell | $166.19 | Sell |
| MA 10 | $164.45 | Buy | $164.66 | Buy |
| MA 20 | $162.61 | Buy | $162.20 | Buy |
| MA 50 | $155.11 | Buy | $163.05 | Buy |
| MA 100 | $175.69 | Sell | $180.70 | Sell |
| MA 200 | $232.89 | Sell | $212.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.37 | Neutral |
| Stoch RSI (14) | 46.18 | Neutral |
| CCI (20) | 68.25 | Neutral |
| Williams %R (14) | -40.36 | Info |
| MACD (12,26,9) | 0.46 | Buy |
| ROC (12) | 4.12 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 59.64 | Neutral |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 9.06 | Buy |
| Ultimate (7,14,28) | 55.56 | Neutral |
| Momentum (10) | 1.25 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 169.36 | Sell |
| ADX (14) | 13.45 | Neutral |
| ATR (14) | 3.24 | Info |
The current price sits near technical levels with a 30-day range of $134.17 to $190.30. The RSI14 is 60, and the price is above the SMA50 of $157.28 while the SMA200 stands at $248.70. Nearby support is listed at $138.97 and resistance at $159.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $138.97 | $165.68 | $208.20 | 0% | Neutral | |
| $153.77 | $188.47 | $241.93 | +14% | Neutral | |
| $181.53 | $227.10 | $300.11 | +37% | Bullish | |
| $195.01 | $248.09 | $335.41 | +50% | Bullish | |
| $196.79 | $254.08 | $350.16 | +53% | Bullish | |
| $204.41 | $267.45 | $374.85 | +61% | Bullish | |
| $207.07 | $274.29 | $390.30 | +66% | Bullish | |
| $226.64 | $303.67 | $438.10 | +83% | Bullish | |
| $259.68 | $351.74 | $513.93 | +112% | Bullish | |
| $271.72 | $371.87 | $549.81 | +124% | Bullish | |
| $354.59 | $508.30 | $789.93 | +207% | Bullish | |
| $589.71 | $913.34 | $1,527.81 | +451% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $138.97 | $165.68 | $192.95 | +0.00% |
| August 2026 | $141.67 | $165.38 | $196.90 | -0.18% |
| September 2026 | $144.54 | $169.78 | $204.19 | +2.66% |
| October 2026 | $147.09 | $173.63 | $210.49 | +2.27% |
| November 2026 | $144.24 | $170.97 | $208.61 | -1.54% |
| December 2026 | $142.59 | $169.64 | $208.20 | -0.78% |
Click any year to see its month-by-month PODD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PODD could reach as high as $208.20, with a base case around $165.68 and support toward $138.97 — roughly 0% from $165.68. Price action looks broadly range-bound.
Expect PODD to range from $153.77 to $241.93 through 2027. The $188.47 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
The PODD price prediction for 2028 points to an average of $227.10 (low $181.53, high $300.11) — a potential gain of +37% on today's $165.68. Momentum favours further upside here.
In 2029, PODD is projected to trade between $195.01 and $335.41, averaging $248.09 — a potential gain of +50% from today's $165.68. That is up +9% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Insulet Corporation's 2030 outlook centres on $254.08, within a $196.79 to $350.16 range. That is up +2% on the projected 2029 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2031, PODD could reach as high as $374.85, with a base case around $267.45 and support toward $204.41 — roughly +61% from $165.68. Buyers look set to stay in control over this stretch.
Expect PODD to range from $207.07 to $390.30 through 2032. The $274.29 average target implies a +66% move from current prices. That is up +3% on the projected 2031 average. Momentum favours further upside here.
The PODD price prediction for 2033 points to an average of $303.67 (low $226.64, high $438.10) — a potential gain of +83% on today's $165.68. Buyers look set to stay in control over this stretch.
In 2034, PODD is projected to trade between $259.68 and $513.93, averaging $351.74 — a potential gain of +112% from today's $165.68. That is up +16% on the projected 2033 average. Momentum favours further upside here.
Insulet Corporation's 2035 outlook centres on $371.87, within a $271.72 to $549.81 range. That is up +6% on the projected 2034 average. That marks a +124% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PODD could reach as high as $789.93, with a base case around $508.30 and support toward $354.59 — roughly +207% from $165.68. Momentum favours further upside here.
Expect PODD to range from $589.71 to $1,527.81 through 2050. The $913.34 average target implies a +451% move from current prices. That is up +80% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PODD today (≈ 6.035732 PODD) could be worth
$5,512.7
+$4,512.7 (+451%) by 2050 · US Dollar
Based on the average projected PODD price of $913.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PODDwould be worth at today's price.
$1,000 invested in PODD on Jul 30, 2025 (≈ 3.352667 PODD) would be worth
$555.47
-$444.53 (-44.5%) today · 0.56× · US Dollar
Based on a PODD entry price of $298.27 vs. today's $165.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $158.38 | $1,046.09 | +4.6% |
| 1 month ago | $152.25 | $1,088.21 | +8.8% |
| 3 months ago | $175.04 | $946.53 | -5.3% |
| 6 months ago | $255.81 | $647.67 | -35.2% |
| 1 year ago | $298.27 | $555.47 | -44.5% |
| All time (5.0y) ago | $278.7 | $594.47 | -40.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PODD forecast.
Our base-case forecast reaches $330.00 around 2034.
Implied market cap at $330.00: $22.86B
The multi-year forecast shows a neutral path in 2026, with an average of $159.79 and ROI of 0%. The outlook turns bullish in subsequent years, with 2027 average $179.85 (ROI 12.6%), 2028 average $214.38 (ROI 34.2%), and 2029 average $240.74 (ROI 50.7%), then 2030 avg $233.42 (ROI 46.1%) and a growing bullish trend through 2035 (2031 avg $242.58, ROI 51.8%; 2032 avg $257.53, ROI 61.2%; 2033 avg $267.66, ROI 67.5%; 2034 avg $314.16, ROI 96.6%; 2035 avg $347.88, ROI 117.7%). The forecast continues bullish in 2040 at avg $448.48 (ROI 180.7%) and reaches 2050 at avg $803.09 (ROI 402.6%), with max values shown as $337.68 (2030), $751.00 (2040), and $1,468.70 (2050).
These are estimates, not guarantees, and reflect potential upside under the provided numbers.
Tap a question to reveal the answer.
2030 min $173.80, avg $233.42, max $337.68; ROI 46.1%; sentiment BULLISH.
Forecasts show neutral in 2026 (avg $159.79; ROI 0) and 2027 (avg $179.85; ROI 12.6), then bullish with higher averages and ROIs through 2050 (e.g., 2040 avg $448.48; ROI 180.7%; 2050 avg $803.09; ROI 402.6%). These are estimates, not guarantees.
Yes—the max forecast for 2050 is $1,468.70, while the 2050 average is $803.09 and the 2040 max is $751.00.
Current price is $159.79 and market cap is $11.07B.
30-day range low is $134.17 and high is $190.30.
Insulet Corporation Community Discussion
0Share your Insulet Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.